Welcome to our dedicated page for Octave Specialty Group SEC filings (Ticker: OSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to SEC filings historically associated with the symbol OSG, including documents filed by Octave Specialty Group, Inc. and, in earlier periods, filings referenced in connection with Overseas Shipholding Group, Inc. These filings can include current reports on Form 8-K, annual and quarterly reports, and transaction-related materials.
An example of a filing for Octave Specialty Group, Inc. is a Form 8-K that identifies Octave Specialty Group, Inc. as the registrant and Ambac Financial Group, Inc. as a former name. The filing explains that on October 31, 2025, Octave Specialty Group completed its previously announced acquisition of Armada Corp Capital, LLC pursuant to a membership interest purchase agreement, with total consideration paid in cash and financed in part with borrowings. The Form 8-K also lists exhibits that include unaudited consolidated financial statements of ArmadaCorp Capital, LLC and subsidiaries for specified periods, audited consolidated financial statements for earlier years, and unaudited pro forma combined financial information of the company.
For Overseas Shipholding Group, Inc., SEC-related materials referenced in public announcements include an Offer to Purchase, a Solicitation/Recommendation Statement on Schedule 14D-9, and a Tender Offer Statement on Schedule TO filed in connection with Saltchuk Resources, Inc.’s tender offer to acquire all issued and outstanding shares of OSG’s Class A common stock. These documents were filed with the U.S. Securities and Exchange Commission and contain detailed terms and conditions of the offer and the board of directors’ recommendation.
On this page, users can review such filings to understand corporate events, acquisitions, and historical financial information associated with entities that have used the OSG symbol. Current reports like Form 8-K highlight material events, including completed acquisitions and related financial statement disclosures. Transaction-related filings, such as tender offer documents and recommendation statements, provide context on changes in ownership and the process by which Overseas Shipholding Group, Inc. became a wholly owned subsidiary of Saltchuk and its shares ceased trading on the New York Stock Exchange, with delisting and deregistration described.
AI-powered tools on the platform can assist by summarizing lengthy filings, highlighting key sections such as descriptions of completed acquisitions, pro forma financial information, and exhibit lists. This can help readers quickly identify the portions of each filing that address corporate transactions, historical financial performance, and changes in corporate structure related to the OSG symbol.
Octave Specialty Group Inc. reported a new equity award to one of its directors. On January 1, 2026, the director received 4,524 restricted stock units (RSUs), each representing a right to receive one share of Octave Specialty Group common stock. The RSUs were recorded at an exercise price of $0 and are held as direct beneficial ownership, bringing the director’s total derivative securities beneficially owned to 8,650.
The RSUs granted on January 1, 2026 are scheduled to fully vest on January 1, 2027. Once vested, they convert into shares of common stock on the vesting date or when the director leaves the Board, unless the director has elected to defer settlement.
Octave Specialty Group Inc. director reports new equity award. A board member of Octave Specialty Group Inc. recorded a grant of 4,524 restricted stock units (RSUs) effective January 1, 2026. Each RSU represents a contingent right to receive one share of the company’s common stock.
The RSUs are scheduled to vest on January 1, 2027. Once vested, they will convert into shares of common stock on the earlier of the vesting date or the date the director leaves the company’s Board of Directors, subject to any deferral election by the reporting person. Following this transaction, the filing shows 8,650 derivative securities beneficially owned on a direct basis.
Octave Specialty Group Inc. director reported receiving restricted stock units that could convert into common shares. On January 1, 2026, the reporting person was granted 4,524 restricted stock units (RSUs), each tied to one share of Octave Specialty Group Inc. common stock. The RSUs are listed with a price of $0 and are shown as a direct holding.
The filing states that these RSUs will vest on January 1, 2027. Once vested, they will settle into shares of common stock on the earlier of the vesting date or the date the director resigns from, or otherwise ceases to be a member of, the company’s Board of Directors, unless the director elects to defer settlement. After this transaction, the filing shows 8,650 derivative securities beneficially owned.
Octave Specialty Group Inc. reported an equity award to a board member. On January 1, 2026, the director received 4,524 restricted stock units (RSUs), each representing a contingent right to one share of Octave Specialty Group common stock. These RSUs are scheduled to vest on January 1, 2027, and any vested RSUs will convert into common shares on the earlier of the vesting date or when the director leaves the Board, unless the director elects to defer settlement. After this grant, the director beneficially owns 8,650 derivative securities in the form of RSUs.
Octave Specialty Group Inc. reported an equity award to a board member in the form of restricted stock units. On January 1, 2026, the director received 4,524 restricted stock units (RSUs), each representing a contingent right to receive one share of Octave Specialty Group common stock. These RSUs are scheduled to vest on January 1, 2027. Once vested, they will convert into common shares on the earlier of the vesting date or the date the director leaves the company’s Board of Directors, unless the director elects to defer settlement. After this grant, the reporting person held a total of 8,650 derivative securities related to the company’s stock in direct ownership.
Octave Specialty Group Inc. reported an equity grant to a board member. A director received 4,524 restricted stock units (RSUs) of Octave Specialty Group Inc. common stock on January 1, 2026. Each RSU represents a right to receive one share of common stock and was granted at a price of $0 per unit. The RSUs are scheduled to vest on January 1, 2027. Once vested, they will convert into common shares on the earlier of the vesting date or the date the director ceases to serve on the company’s Board of Directors, unless the director elects to defer settlement. Following this grant, the reporting person holds 8,650 derivative securities directly.
Octave Specialty Group Inc. director and Chief Executive Officer reported buying additional company stock. On 01/02/2026, a Form 4 shows an open-market purchase of 12,000 shares of common stock at a price of $7.59 per share, coded as an acquisition transaction. After this trade, the reporting person beneficially owns 1,033,777 shares of Octave Specialty Group Inc. common stock in direct ownership. The filing reflects a single, straightforward insider purchase with no derivative securities activity disclosed.
Octave Specialty Group Inc. disclosed that one of its officers, serving as Senior Managing Director and General Counsel, filed an initial insider ownership report effective 12/11/2025.
The report states that this reporting person currently has no securities beneficially owned, and it was signed by attorney-in-fact William J. White on 12/17/2025.
FAQ
What is the current stock price of Octave Specialty Group (OSG)?
What is the market cap of Octave Specialty Group (OSG)?
